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We report a case of fungemia due to fluconazole'resistant Candida
nivariensis (MIC, >128 pg/mD. Internal transcribed spacer PCR followed by
microchip gel electrophoresis with positive'testing blood culture revealed a
unique pattern different from those of other pathogenic yeast.
CASE REPORT
A 7O-yearold woman with rheumatoid arthritis was hospitalized for
treatment of nutritional disorder in September 2006. The patient had
received total parenteral nutrition for two months before admission. On day
20, the patient had a fever of 37.8"C, which continued for 5 days. Urine and
stool cultures yielded C. albicans, while catheter-tip and blood cultures were




intravenous fluconazole (400 mg dailt for 27 days. On day 77,
patient developed a high fever of 40"C. Blood was drawn for
the central venous catheter was removed. Hematological
investigations revealed a hemoglobin level of 11.6 g/dl, platelet count of
139x10sniter, and a white cell count of 6.6x10s/liter. C'reactive protein was 6
mg/Iiter, and (1-3)'B-D-glucan level was 153.7 pgAiter. Serum Candida
antigen was positive with the Unimedi Candida monotest (Unitica Ltd.,
Tokyo, Japad. The Bact/Alert blood culture system (Organon Teknika Qo"p.,
Durham, NC) signaled microbi.t gxo*th on the day after blood collection. As
Gram staining of the blood culture showed yeast, intravenous fluconazole
(aOO mg daily) was commenced as empirical therapy. Catheter-tip culture
also grew yeast in pure culture. Despite fluconazole administration, the
patient remained febrile, and blood culture performed during fluconazole
treatment was again positive for yeast. Therefore, the treatment was
changed to intravenous voriconazole (aOO mg daily) and micafungin (t5O mg
daily) for 7 days based on the results of broth microdilution susceptibility
testing performed using a commercial kit (0). ttre MICs of the isolate were as
follows: 0.5 pg/ml for amphotericin-B, 2.0 pg/ml for 5-fluorocytosine, 2 pg/ml
for miconazole, >16 pg/ml for itraconazole, >128 pg/ml for fluconazole, 4
pg/ml for voriconazohe, and 0.06 pg/ml for micafungrn. The fever resolved 4
days later, and the patient was given MCFG for a further 10 days. There was
no evidence of relapse during the next month, when she was transferred to
another hospital.
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Nuclear DNA extraction from the yeast-positive blood culture bottles and
PCR amplification of internal transcribed spacers (ITS) followed by
microchip gel electrophoresis are routinely performed in our laboratory as
d.escribed previously (g,a) with the following changes: (il usage of a
MagExtract DNA extraction kit was omitted, and (iil PCR cycling set at' 25
cycles. It took approximately 50 min to extract DNA from positive blood
culture bottles. The PCR procedure required 35 min, and electrophoresis
took 5 min. Therefore, the overall turnaround time of the PCR ITS assay was
approximately 1.5 h. ITS'PCR of the three isolates (two from blood cultures
and one from cathetertip culture) with universal primers ITS1 and ITS4
yielded fragments ?65 to 768 bp in length, while universal primers ITSB and
ITS4 yielded fragments 411 to 4l4bp in length. The ITS'PCR pattern of the
isolate has not yet been found in our in'house ITS-PCR database (g). the
three isolates were identified as Candida glabrata with the ID32C yeast
identifi.cation system (bioMerieux, Marcy I'Etoile, France). The ID32C code
obtained was 0001'0002-01, which showed an excellent match with the
profrle for C. glabrata in the APILAB database (ID96.9o/o, T0.94). However,
the ITS'PCR pattern differed from those of C. glabrata(Fig,.1). Furthermore,
the colonies of the
contrast to those
isolates on CHROMagar Candida medium were white in
of C. glabrata, which are pink. The ITS2 region was
sequenced to confirm identification of the isolate using an ABI Prism 377
automated DNA sequencer (Applied Biosytems, Foster City, CA) with a
BigDye Tbrminator cycle sequencing kit (Applied Biosystems). The primers
used for sequencing ITS regions were ITS1, ITS2, ITS3, and ITS4 (Z). Tne
ITS2 sequence was compared using nucleotide'nucleotide BI"ASI (blastn)
with default settings, and the isolate showed a high level of similarity (99o/,
nucleotide identity, 218 of 219) with the sequence of a C. niuariensis
(GenBank accession no. AY620gfZ); the isolate differed only one bp for the
ITS2 region (a conversion of T toAin position 80) from lhe C.nivariensr^stype
strain (CBS 9983T). The lengths of ITS1 and ITS2 regions of the blood isolate
were 283 bp and 232 bp, respectively. In contrast, the length of ITS1 of C.
glabrata ranged from 399 bp to 4D2bp, and that of ITS2 ranged from 233 to
238 bp (GenBank accession no. .{8032177, AF167993, A\/1492797, and
A\tr429798).
C. nivariensr^s is a recently described pathogenic yeast closely related to C.
glabrata, and only four cases of C. nivariensis infection have been reportedi
three from Spain (1) and one from Ind.onesia (GenBank accession no.
EF05 6322). C. nivariensis isolates have been misidentified as C. glabrata
using commercial identification kits (1). The same misidentification was
made with the strains isolated from the patient in the present stud.y.
CHROMagar Candida medium seems to be useful to d.ifferentiate C. glabrata
and C- niuariensis.-However, a PCR'based technique is needed for rapid and
specific identification of C. nivariensis(1,2).It is well known that C. glabrata
and C. krusei are resistant or intermediately susceptible to fluconazole (b),
but no susceptibility testing for C. niuariensis has been reported.. Although
the blood isolate was resistant to fluconazole, further studies are need.ed. to
determine whether strains belonging to C. nivariensis species are resist4nt
to azole antifungal agents.
In conclusion, if the patient had been treated. previously with an azole, the
possibility of. C. nivariensis infection must be considered as shown in the
present study. ITS PCR pattern analysis can not only reliably identlty C.
nivariensis, but is also straightforward and can be completed within 1.b h
from positive'testing blood culture bottles.
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FIG. 1. ITS-PCR patterns of C.nivariensis K16661 (A), C.glabrata K432 (B),
C.gIabrataKLzIOT (C), and CglabrataKl\zIz (D). Arrows indicate DNAsize
markers of 100 bp (ten) and 1,000 bp (right), and asterisks indicate PCR
products (A, 4L2 and 768 bpi B, 419 and 884 bp; C, 422 and 878




: [andidl gfahr'*l {31
B














mo mmff i  th l
